Piper Sandler Upgrades Immunogen Inc. (IMGN) to Overweight
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 82
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 82
Join SI Premium – FREE
Piper Sandler analyst Joseph Catanzaro upgraded Immunogen Inc. (NASDAQ: IMGN) from Neutral to Overweight with a price target of $16.00.
For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.
Shares of Immunogen Inc. closed at $5.20 yesterday.
You May Also Be Interested In
- US Tiger Securities Upgrades Circle Internet Group (CRCL) to Buy, 'anchored in our more constructive view on Bitcoin'
- Zelman & Associates Upgrades NVR Inc. (NVR) to Buy
- Zelman & Associates Upgrades D.R. Horton (DHI) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
